The drug is intended for children: with reduced appetite; with physical and mental overloads in schoolchildren; with developmental delays; as an adjunct in the treatment of antibiotics; with seasonal deficiency of fruits and vegetables in the diet.
Composition and form of release
Active components of Univit:
- folic acid;
- vitamin A;
- vitamin B6;
- vitamin B1;
- vitamin D3;
- vitamin B2;
- vitamin PP;
- vitamin B5;
- vitamin C;
- vitamin B12.
Univit’s release form is film-coated tablets.
The product contains a combination of vitamins and minerals (phosphorus and calcium). It is used in children for the treatment and prevention of deficiency of calcium, vitamins, phosphorus.
Univit is indicated for the prevention and treatment of mineral and vitamin deficiencies in children with:
– conditions requiring improvement of immunological status, metabolism, endocrine gland function;
– unbalanced, malnutrition;
– antibiotic treatment;
– conditions, accompanied by an increased need for minerals and vitamins (illness, recovery period, growth period).
Univit is contraindicated in case of hypersensitivity to it, chronic glomerulonephritis, hypervitaminosis D3 or / and A, thrombophlebitis, nephrolithiasis, erythremia, gout, sarcoidosis, hyperuricemia, chronic heart failure, erythrocytosis, hypercalcemia, thrombosis / thrombosis / thrombosis stomach.
Univit is not used in children under four years of age.
Application during pregnancy and lactation
Univit is intended for use exclusively in children.
Method of administration and dosage
The pharmaceutical product Univit should be taken after meals.
To prevent a lack of minerals and vitamins, this drug is used in the following dosage:
– children four to six years old – one Univita tablet once or twice a day;
– children seven to fourteen years old – one tablet two to three times / day.
For the treatment of mineral deficiencies and hypovitaminosis, Univit is used in the following dosage:
– children four to six years old – one tablet four to five times / day;
– children seven to fourteen years old – one tablet five to seven times a day.
The duration of the use of this pharmaceutical agent is determined by the attending doctor for each patient individually. With reduced appetite, it is recommended to use the drug for two months.
When using Univit in recommended doses, the development of an overdose is unlikely.
Diarrhea may occur if you take more than recommended doses of this drug.
Long-term use of this pharmaceutical product in very high doses can lead to the development of hypervitaminosis D3 and A.
In case of an overdose, the patient is shown symptomatic treatment.
The drug Univit is usually well tolerated by patients, however, in some cases, undesirable effects may occur (mainly when using the drug in high doses).
Some children may experience hypersensitivity reactions while using this drug, including angioedema, bronchospasm, anaphylactic shock.
In general, during the use of Univit in children, the following side effects may occur: headaches, nausea, dizziness, belching, drowsiness, vomiting, urticaria, abdominal pain, constipation / diarrhea, skin rashes, pyrexia, itching, flushing (redness) of the skin , discoloration of urine (yellow staining), hyperhidrosis (sweating).
Storage conditions and periods
Store the pharmaceutical product Univit at temperatures below + 25 ° C, in places inaccessible to the child.
The shelf life of Univit tablets is two years.